Gene expression profiles of cholinergic nucleus basalis neurons in Alzheimer's disease

Neurochemical Research

Volumn 27, Issue 10, 2002, Pages 1035-1048

  Mufson, Elliott J ^a   Counts, Scott E ^a   Ginsberg, Stephen D ^b  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cathepsin D; CDNA microarray; Cholinergic basal forebrain; RNA amplification; Synaptophysin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; CATHEPSIN D; NEUROTROPHIN RECEPTOR; PHOSPHOPROTEIN PHOSPHATASE; SYNAPTOPHYSIN; SYNAPTOTAGMIN;

ALZHEIMER DISEASE; ARTICLE; CHOLINERGIC NERVE; CHOLINERGIC TRANSMISSION; COMPLEX FORMATION; DNA MICROARRAY; FOREBRAIN; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; NEUROFIBRILLARY TANGLE; OLIVARY NUCLEUS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; SYNAPTIC TRANSMISSION;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID; BASAL NUCLEUS OF MEYNERT; CATHEPSIN D; CHOLINERGIC FIBERS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; ISOENZYMES; MALE; NEURONS; PHOSPHOPROTEIN PHOSPHATASE; RECEPTOR, NERVE GROWTH FACTOR; RECEPTORS, NERVE GROWTH FACTOR; RNA, MESSENGER;

EID: 0036808469     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020952704398     Document Type: Article

References (96)

1. Bartus, R. T., Dean, R. L., 3rd, Beer, B., and Lippa, A. S. 1982. The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-414.
2. Bierer, L. M., Haroutunian, V., Gabriel, S., Knott, P. J., Carlin, L. S., Purohit, D. P., Perl, D. P., Schmeidler, J., Kanof, P., and Davis, K. L. 1995. Neurochemical correlates of dementia severity in Alzheimer's disease: relative importance of the cholinergic deficits. J. Neurochem. 64:749-760.
3. Geula, C. 1998. Abnormalities of neural circuitry in Alzheimer's disease: hippocampus and cortical cholinergic innervation. Neurology 51:S18-S29; discussion S65-S67.
4. Wilcock, G. K., Esiri, M. M., Bowen, D. M., and Smith, C. C. 1982. Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57:407-417.
5. Mesulam, M. M., Mufson, E. J., Levey, A. I., and Wainer, B. H. 1983. Cholinergic innervation of cortex by the basal forebrain: Cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J. Comp. Neurol. 214:170-197.
6. Baxter, M. G. and Chiba, A. A. 1999. Cognitive functions of the basal forebrain. Curr. Opin. Neurobiol. 9:178-183.
7. Davies, P. and Maloney, A. J. 1976. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2:1403.
8. Mufson, E. J., Bothwell, M., and Kordower, J. H. 1989. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: A quantitative analysis across subregions of the basal forebrain. Exp. Neurol. 105:221-232.
9. Whitehouse, P. J., Price, D. L., Struble, R. G., Clark, A. W., Coyle, J. T., and Delon, M. R. 1982. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain. Science 215:1237-1239.
10. Chu, Y., Cochran, E. J., Bennett, D. A., Mufson, E. J., and Kordower, J. H. 2001. Down-regulation of trkA mRNA within nucleus basalis neurons in individuals with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 437:296-307.
11. Mufson, E. J., Ma, S. Y., Cochran, E. J., Bennett, D. A., Beckett, L. A., Jaffar, S., Saragovi, H. U., and Kordower, J. H. 2000. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 427:19-30.
12. Mufson, E. J., Ma, S. Y., Dills, J., Cochran, E. J., Leurgans, S., Wuu, J., Bennett, D. A., Jaffar, S., Gilmor, M. L., Levey, A. I., and Kordower, J. H. 2002. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease. J. Comp. Neurol. 443:136-153.
13. Kordower, J. H., Gash, D. M., Bothwell, M., Hersh, L., and Mufson, E. J. 1989. Nerve growth factor receptor and choline acetyltransferase remain colocalized in the nucleus basalis (Ch4) of Alzheimer's patients. Neurobiol. Aging 10:67-74.
14. Mufson, E. J., Lavine, N., Jaffar, S., Kordower, J. H., Quirion, R., and Saragovi H. U. 1997. Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:91-103.
15. Davis, K. L., Mohs, R. C., Marin, D., Purohit, D. P., Perl, D. P., Lantz, M., Austin, G., and Haroutunian, V. 1999. Cholinergic markers in elderly patients with early signs of Alzheimer disease. JAMA 281:1401-1406.
16. DeKosky, S. T., Harbaugh, R. E., Schmitt, F. A., Bakay, R. A., Chui, H. C., Knopman, D. S., Reeder, T. M., Shetter, A. G., Senter, H. J., and Markesbery, W. R. 1992. Cortical biopsy in Alzheimer's disease: Diagnostic accuracy and neurochemical, neuropathological, and cognitive correlations. Intraventricular Bethanecol Study Group. Ann. Neurol. 32:625-632.
17. DeKosky, S. T., Ikonomovic, M. D., Styren, S. D., Beckett, L., Wisniewski, S., Bennett, D. A., Cochran, E. J., Kordower, J. H., and Mufson, E. J. 2002. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51:145-155.
18. Gilmor, M. L., Erickson, J. D., Varoqui, H., Hersh, L. B., Bennett, D. A., Cochran, E. J., Mufson, E. J., and Levey, A. I. 1999. Preservation of nucleus basalis neurons containing choline acetyltransferase and the vesicular acetylcholine transporter in the elderly with mild cognitive impairment and early Alzheimer's disease. J. Comp. Neurol. 411:693-704.
19. Cullen, K. M. and Halliday, G. M. 1998. Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology. Neurobiol. Aging 19:297-306.
20. Price, J. L., Davis, P. B., Morris, J. C., and White, D. L. 1991. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol. Aging 12:295-312.
21. Sassin, I., Schultz, C., Thal, D. R., Rub, U., Arai, K., Braak, E., and Braak, H. 2000. Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert. Acta Neuropathol. (Berl.) 100:259-269.
22. Alonso, A. C., Grundke-Iqbal, I., and Iqbal, K. 1996. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 2:783-787.
23. Cleveland, D. W., Hwo, S. Y., and Kirschner, M. W. 1977. Purification of tau, a microtubule-associated protein that induces assembly of microtubules from purified tubulin. J. Mol. Biol. 116:207-225.
24. Callahan, L. M. and Coleman, P. D. 1995. Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease. Neurobiol. Aging 16:311-314.
25. Ginsberg, S. D., Hemby, S. E., Lee, V. M., Eberwine, J. H., and Trojanowski, J. Q. 2000. Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann. Neurol. 48:77-87.
26. Stamer, K., Vogel, R., Thies, E., Mandelkow, E., and Mandelkow, E. M. 2002. Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress. J. Cell. Biol. 156:1051-1063.
27. Masliah, E., Mallory, M., Hansen. L., DeTeresa, R., Alford, M., and Terry R. 1994. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 174:67-72.
28. Selkoe, D. J. 1999. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399:A23-A31.
29. Struble, R. G., Cork, L. C., Whitehouse, P. J., and Price, D. L. 1982. Cholinergic innervation in neuritic plaques. Science 216: 413-415.
30. Callahan, L. M., Chow, N., Cheetham, J. E., Cox, C., and Coleman, P. D. 1998. Analysis of message expression in single neurons of Alzheimer's disease brain. Neurobiol. Aging 19:S99-S105.
31. Chow, N., Cox, C., Callahan, L. M., Weimer, J. M., Guo, L., and Coleman, P. D. 1998. Expression profiles of multiple genes in single neurons of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 95:9620-9625.
32. Crino, P., Khodakhah, K., Becker, K., Ginsberg, S., Hemby, S., and Eberwine, J. 1998. Presence and phosphorylation of transcription factors in developing dendrites. Proc. Natl. Acad. Sci. USA 95:2313-2318.
33. Eberwine, J., Yeh, H., Miyashiro, K., Cao, Y., Nair, S., Finnell, R., Zettel, M., and Coleman, P. 1992. Analysis of gene expression in single live neurons. Proc. Natl. Acad. Sci. USA 89: 3010-3014.
34. Eberwine J., Kacharmina, J. E., Andrews, C., Miyashiro, K., McIntosh, T., Becker, K., Barrett, T., Hinkle, D., Dent, G., and Marciano, P. 2001. mRNA expression analysis of tissue sections and single cells. J. Neurosci. 21:8310-8314.
35. Ginsberg, S. D., Crino, P. B., Hemby, S. E., Weingarten, J. A., Lee, V. M., Eberwine, J. H., and Trojanowski, J. Q. 1999. Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques. Ann. Neurol. 45:174-181.
36. Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Beckett, L. A., Aggarwal, N. T., Barnes, L. L., Fox, J. H., and Bach, J. 2002. Natural history of mild cognitive impairment in older persons. Neurology, 59:198-205.
37. Kordower, J. H., Chu, Y., Stebbins, G. T., DeKosky, S. T., Cochran, E. J., Bennett, D., and Mufson, E. J. 2001. Loss and atrophy of layer II entorhinal cortex neurons in elderly people with mild cognitive impairment. Ann Neurol. 49:202-213.
38. Mufson, E. J., Chen, E. Y., Cochran, E. J., Beckett, L. A., Bennett, D. A., and Kordower, J. H. 1999. Entorhinal cortex beta-amyloid load in individuals with mild cognitive impairment. Exp. Neurol. 158:469-490.
39. Bennett, D. A., Shannon, K. M., Beckett, L. A., Goetz, C. G., and Wilson, R. S. 1997. Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale. Neurology 49:1580-1587.
40. Bennett, D. A., Shannon, K. M., Beckett, L. A., and Wilson, R. S. 1999. Dimensionality of parkinsonian signs in aging and Alzheimer's disease. J. Gerontol. A. Biol. Sci. Med. Sci. 54: M191-M196.
41. Goldstein, L. B., Bertels, C., and Davis, J. N. 1989. Interrater reliability of the NIH stroke scale. Arch. Neurol. 46:660-662.
42. Goldstein, L. B. and Samsa, G. P. 1997. Reliability of the National Institutes of Health Stroke Scale. Extension to non-neurologists in the context of a clinical trial. Stroke 28:307-310.
43. Folstein, M. F., Folstein, S. E., and McHugh, P. R. 1975. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:189-198.
44. Morris, J. C., Heyman, A., Mobs, R. C., Hughes, J. P., van Belle, G., Fillenbaum, G., Mellits, E. D., and Clark, C. 1989. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease. Neurology 39:1159-1165.
45. Beckett, L. A., Wilson, R. S., Bennett, D. A., and Morris, M. C. 1997. Around the WORLD backward: An algorithm for scoring the MMSE WORLD item. Neurology 48:1733-1734.
46. Pittman, J., Andrews, H., Tatemichi, T., Link, B., Struening, E., Stern, Y., and Mayeux, R. 1992. Diagnosis of dementia in a heterogeneous population. A comparison of paradigm-based diagnosis and physician's diagnosis. Arch. Neurol. 49:461-467.
47. Snowdon, D. A., Kemper, S. J., Mortimer, J. A., Greiner, L. H., Wekstein, D. R., and Markesbery, W. R. 1996. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA 275: 528-532.
48. McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., and Stadlan, E. M. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939-944.
49. Hyman, B. T. and Trojanowski, J. Q. 1997. Consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute Working Group on diagnostic criteria for the neuropathological assessment of Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:1095-1097.
50. Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., van Belle, G., and Berg, L. 1991. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 41:479-486.
51. Ginsberg, S. D., Crino, P. B., Lee, V. M., Eberwine, J. H., and Trojanowski, J. Q. 1997. Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques. Ann. Neurol. 41:200-209.
52. Ginsberg, S. D., Galvin, J. E., Chiu, T. S., Lee, V. M., Masliah, E., and Trojanowski, J. Q. 1998. RNA sequestration to pathological lesions of neurodegenerative diseases. Acta Neuropathol. (Berl.) 96:487-494.
53. Van Deerlin, V. M. D., Ginsberg, S. D., Lee, V. M.-Y., and Trojanowski, J. Q. 2002. The use of fixed human postmortem brain tissue to study mRNA expression in neurodegenerative diseases: Applications of microdissection and mRNA amplification. Pages 201-235, in Geschwind, D. H. and Gregg, J. (eds.), Microarrays for the Neurosciences: An Essential Guide, MIT Press, Boston.
54. Kordower, J. H., Bartus, R. T., Bothwell, M., Schatteman, G., and Gash, D. M. 1988. Nerve growth factor receptor immunoreactivity in the nonhuman primate (Cebus apella): Distribution, morphology, and colocalization with cholinergic enzymes. J. Comp. Neurol. 277:465-486.
55. Mufson, E. J., Bothwell, M., Hersh, L. B., and Kordower, J. H. 1989. Nerve growth factor receptor immunoreactive profiles in the normal, aged human basal forebrain: Colocalization with cholinergic neurons. J. Comp. Neurol. 285:196-217.
56. Schatteman, G. C., Gibbs, L., Lanahan, A. A., Claude, P., and Bothwell, M. 1988. Expression of NGF receptor in the developing and adult primate central nervous system. J. Neurosci. 8: 860-873.
57. Hancock, W. W., Becker, G. J., and Atkins, R. C. 1982. A comparison of fixatives and immunohistochemical technics for use with monoclonal antibodies to cell surface antigens. Am. J. Clin. Pathol. 78:825-831.
58. Roses, A. D. and Saunders, A. M. 1994. APOE is a major susceptibility gene for Alzheimer's disease. Curr. Opin. Biotechnol. 5:663-667.
59. Che, S. and Ginsberg, S. D. 2002. Amplification of transcripts using terminal continuation. Nat. Biotechnol. Submitted.
60. Ginsberg, S. D. and Che, S. 2002. RNA amplification in brain tissues. Neurochem. Res. 27:981-992.
61. Ginsberg, S. D., Schmidt, M. L., Crino, P. B., Eberwine, J. H., Lee, V. M.-Y., and Trojanowski, J. Q. 1999. Molecular pathology of Alzheimer's disease and related disorders. Pages 603-653, in Peters, A. and Morrison, J. H. (eds.), Cerebral Cortex, vol. 14. Neurodegenerative and Age-related Changes in Structure and Function of Cerebral Cortex, Kluwer Academic/Plenum, New York.
62. Hemby, S. E., Ginsberg, S. D., Brunk, B., Arnold, S. E., Overton, C., Trojanowski, J. Q., and Eberwine, J. H. 2002. A mRNA expression profile for schizophrenia: single-neuron transcription patterns from the entorhinal cortex. Arch. Gen. Psychiat. 59:631-640.
63. Hemby, S. E. Trojanowski, J. Q., and Ginsberg, S. D. 2002. Neuron specific age related decreases in dopamine receptor subtype mRNAs. J. Comp. Neurol., in press.
64. Barbacid, M. 1994. The Trk family of neurotrophin receptors. J Neurobiol 25:1386-1403.
65. Boissiere, F., Faucheux, B., Ruberg, M., Agid, Y., and Hirsch, E. C. 1997. Decreased TrkA gene expression in cholinergic neurons of the striatum and basal forebrain of patients with Alzheimer's disease. Exp. Neurol. 145:245-252.
66. Mufson, E. J., Li, J. M., Sobreviela, T., and Kordower, J. H. 1996. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. Neuroreport 8:25-29.
67. Ernfors, P., Lindefors, N., Chan-Palay, V., and Persson, H. 1990. Cholinergic neurons of the nucleus basalis express elevated levels of nerve growth factor receptor mRNA in senile dementia of the Alzheimer's type. Dementia 1:138-145.
68. Vogels, O. J., Broere, C. A., ter Laak, H. J., ten Donkelaar, H. J., Nieuwenhuys, R., and Schulte, B. P. 1990. Cell loss and shrinkage in the nucleus basalis Meynert complex in Alzheimer's disease. Neurobiol. Aging 11:3-13.
69. Gibbs, R. B. and Pfaff, D. W. 1992. Effects of estrogen and fimbria/fornix transection on p75NGFR and ChAT expression in the medial septum and diagonal band of Broca. Exp. Neurol. 116:23-39.
70. Kordower, J. H., Chen, E. Y., Sladek, J. R., Jr., and Mufson, E. J. 1994. trk-immunoreactivity in the monkey central nervous system: forebrain. J. Comp. Neurol. 349:20-35.
71. Sobreviela, T., Clary, D. O., Reichardt, L. F., Brandabur, M. M., Kordower, J. H., and Mufson. E. J. 1994. TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin. J. Comp. Neurol. 350:587-611.
72. Boissiere, F., Faucheux, B., Agid, Y., and Hirsch, E. C. 1997. Expression of catalytic trkB gene in the striatum and the basal forebrain of patients with Alzheimer's disease: An in situ hybridization study. Neurosci. Lett. 221:141-144.
73. Salehi, A., Verhaagen, J., Dijkhuizen, P. A., and Swaab, D. F. 1996. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience 75:373-387.
74. Mufson, E. J., Kroin, J. S., Sendera, T. J., and Sobreviela, T. 1999. Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57:451-484.
75. Wetmore, C., Cao, Y. H., Pettersson, R. F., and Olson, L. 1991. Brain-derived neurotrophic factor: Subcellular compartmentalization and interneuronal transfer as visualized with anti-peptide antibodies. Proc. Natl. Acad. Sci. USA 88:9843-9847.
76. Hashimoto, Y., Abiru, Y., Nishio, C., and Hatanaka, H. 1999. Synergistic effects of brain-derived neurotrophic factor and ciliary neurotrophic factor on cultured basal forebrain cholinergic neurons from postnatal 2-week-old rats. Brain Res. Dev. Brain Res. 115:25-32.
77. Nonomura, T., Nishio, C., Lindsay, R. M., and Hatanaka, H. 1995. Cultured basal forebrain cholinergic neurons from postnatal rats show both overlapping and non-overlapping responses to the neurotrophins. Brain. Res. 683:129-139.
78. Allen, S. J., Wilcock, G. K., and Dawbarn, D. 1999. Profound and selective loss of catalytic TrkB immunoreactivity in Alzheimer's disease. Biochem. Biophys. Res. Commun. 264:648-651.
79. Ferrer, I., Marin, C., Rey, M. J., Ribalta, T., Goutan, E., Blanco, R., Tolosa, E., and Marti, E. 1999. BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies. J. Neuropathol. Exp. Neurol. 58:729- 739.
80. Hock, C., Heese, K., Hulette, C., Rosenberg, C., and Otten, U. 2000. Region-specific neurotrophin imbalances in Alzheimer disease: Decreased levels of brain-derived neurotrophic factor and increased levels of nerve growth factor in hippocampus and cortical areas. Arch. Neurol. 57:846-851.
81. Boissiere, F., Hunot, S., Faucheux, B., Mouatt-Prigent, A., Agid, Y., and Hirsch, E. C. 1994. High affinity neurotrophin receptors in cholinergic neurons in the human brain. C. R. Acad. Sci. III 317:997-1003.
82. Savaskan, E., Muller-Spahn, F., Olivieri, G., Bruttel, S., Otten, U., Rosenberg, C., Hulette, C., and Hock, C. 2000. Alterations in trk A, trk B and trk C receptor immunoreactivities in parietal cortex and cerebellum in Alzheimer's disease. Eur. Neurol. 44: 172-180.
83. Masliah, E., Mallory, M., Alford, M., DeTeresa, R., Hansen, L. A., McKeel, D. W., Jr., and Morris, J. C. 2001. Altered expression of synaptic proteins occurs early during progression of Alzheimer's disease. Neurology 56:127-129.
84. Davidsson, P. and Blennow, K. 1998. Neurochemical dissection of synaptic pathology in Alzheimer's disease. Int. Psychogeriatr. 10:11-23.
85. DeKosky, S. T. and Scheff, S. W. 1990. Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity. Ann. Neurol. 27:457-464.
86. Loring, J. F., Wen, X., Lee, J. M., Seilhamer, J., and Somogyi, R. 2001. A gene expression profile of Alzheimer's disease. DNA Cell Biol. 20:683-695.
87. Fernandez-Chacon, R. and Sudhof, T. C. 1999. Genetics of synaptic vesicle function: Toward the complete functional anatomy of an organelle. Annu. Rev. Physiol. 61:753-776.
88. Iqbal, K., Alonso, A. D., Gondal, J. A., Gong, C. X., Haque, N., Khatoon, S., Sengupta, A., Wang, J. Z., and Grundke-Iqbal, I. 2000. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach. J. Neural. Transm. Suppl. 59: 213-222.
89. Baum, L., Seger, R., Woodgett, J. R., Kawabata, S., Maruyama, K., Koyama, M., Silver, J., and Saitoh, T. 1995. Overexpressed tau protein in cultured cells is phosphorylated without formation of PHF: Implication of phosphoprotein phosphatase involvement. Brain Res. Mol. Brain Res. 34:1-17.
90. Merrick, S. E., Trojanowski, J. Q., and Lee, V. M. 1997. Selective destruction of stable microtubules and axons by inhibitors of protein serine/threonine phosphatases in cultured human neurons. J. Neurosci. 17:5726-5737.
91. Pearson, R. C., Esiri, M. M., Hiorns, R. W., Wilcock, G. K., and Powell, T. P. 1985. Anatomical correlates of the distribution of the pathological changes in the neocortex in Alzheimer disease. Proc. Natl. Acad. Sci. USA 82:4531-4534.
92. Brun, A. and Englund, E. 1981. Regional pattern of degeneration in Alzheimer's disease: Neuronal loss and histopathological grading. Histopathology 5:549-564.
93. Cataldo, A. M., Barnett, J. L., Berman, S. A., Li, J., Quarless, S., Bursztajn, S., Lippa, C., and Nixon, R. A. 1995. Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system. Neuron 14:671-680.
94. Cataldo, A. M., Hamilton, D. J., Barnett, J. L., Paskevich, P. A., and Nixon, R. A. 1996. Properties of the endosomal-lysosomal system in the human central nervous system: disturbances mark most neurons in populations at risk to degenerate in Alzheimer's disease. J. Neurosci. 16:186-199.
95. Cataldo, A. M., Barnett, J. L., Pieroni, C., and Nixon, R. A. 1997. Increased neuronal endocytosis and protease delivery to early endosomes in sporadic Alzheimer's disease: Neuropathologic evidence for a mechanism of increased beta-amyloidogenesis. J. Neurosci. 17:6142-6151.
96. Mathews, P. M., Guerra, C. B., Jiang, Y., Grbovic, O. M., Kao, B. H., Schmidt, S. D., Dinakar, R., Mercken, M., Hille-Rehfeld, A., Rohrer, J., Mehta, P., Cataldo, A. M., and Nixon, R. A. 2002. Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: Role for altered lysosomal hydrolase distribution in beta-amyloidogenesis. J. Biol. Chem, 277:5299-5307.